1. Home
  2. TTEK vs RGEN Comparison

TTEK vs RGEN Comparison

Compare TTEK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

HOLD

Current Price

$34.23

Market Cap

8.6B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.14

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEK
RGEN
Founded
1966
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.2B
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
TTEK
RGEN
Price
$34.23
$165.14
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$43.25
$170.90
AVG Volume (30 Days)
3.2M
826.7K
Earning Date
11-12-2025
10-28-2025
Dividend Yield
0.76%
N/A
EPS Growth
N/A
N/A
EPS
0.93
0.03
Revenue
$4,617,360,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$6.70
$12.57
P/E Ratio
$36.71
$5,343.41
Revenue Growth
6.84
11.74
52 Week Low
$27.27
$102.97
52 Week High
$43.50
$182.52

Technical Indicators

Market Signals
Indicator
TTEK
RGEN
Relative Strength Index (RSI) 49.74 58.40
Support Level $34.13 $161.67
Resistance Level $35.60 $170.40
Average True Range (ATR) 0.94 5.85
MACD 0.01 0.09
Stochastic Oscillator 43.31 67.15

Price Performance

Historical Comparison
TTEK
RGEN

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: